Jørstad ØK - Search Results

1

Could optical coherence tomography add to the history of the pituitary incidentaloma?

Jørstad ØK, Wigers AR, Marthinsen PB, Evang JA, Moe MC. Jørstad ØK, et al. Acta Ophthalmol. 2019 Dec;97(8):e1157-e1158. doi: 10.1111/aos.14151. Epub 2019 Jun 11. Acta Ophthalmol. 2019. PMID: 31184420 Free article. No abstract available.

2

[Health requirements for driving licences – on the right path with new technology].

Sudmann TM, Brækhus A, Jørstad ØK. Sudmann TM, et al. Among authors: jorstad ok. Tidsskr Nor Laegeforen. 2022 Nov 7;142(16). doi: 10.4045/tidsskr.22.0607. Print 2022 Nov 8. Tidsskr Nor Laegeforen. 2022. PMID: 36345625 Free article. Norwegian. No abstract available.

3

Initial improvements when converting eyes with treatment-resistant exudative AMD to aflibercept are substantially diminished after increasing treatment intervals from 4 to 8 weeks.

Jørstad ØK, Faber RT, Moe MC. Jørstad ØK, et al. Acta Ophthalmol. 2015 Sep;93(6):e510-1. doi: 10.1111/aos.12681. Epub 2015 Feb 23. Acta Ophthalmol. 2015. PMID: 25708506 Free article. No abstract available.

4

Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol.

Jørstad ØK, Faber RT, Moe MC. Jørstad ØK, et al. Acta Ophthalmol. 2017 Aug;95(5):460-463. doi: 10.1111/aos.13480. Epub 2017 May 29. Acta Ophthalmol. 2017. PMID: 28556485 Free article.

5

Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties.

Sivertsen MS, Jørstad ØK, Grevys A, Foss S, Moe MC, Andersen JT. Sivertsen MS, et al. Among authors: jorstad ok. Sci Rep. 2018 Feb 1;8(1):2101. doi: 10.1038/s41598-018-20525-8. Sci Rep. 2018. PMID: 29391560 Free PMC article.

6

Loss of horizontal macular ganglion cell complex asymmetry: an optical coherence tomography indicator of chiasmal compression.

Jørstad ØK, Wigers AR, Marthinsen PB, Moe MC, Evang JA. Jørstad ØK, et al. BMJ Open Ophthalmol. 2018 Oct 25;3(1):e000195. doi: 10.1136/bmjophth-2018-000195. eCollection 2018. BMJ Open Ophthalmol. 2018. PMID: 30519642 Free PMC article.

7

The Human Visual Pathway Communicates Directly With the Subarachnoid Space.

Jacobsen HH, Ringstad G, Jørstad ØK, Moe MC, Sandell T, Eide PK. Jacobsen HH, et al. Among authors: jorstad ok. Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2773-2780. doi: 10.1167/iovs.19-26997. Invest Ophthalmol Vis Sci. 2019. PMID: 31247084

8

Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway.

Jørstad ØK, Steffensen LA, Eriksen K, Bragadóttir R, Moe MC. Jørstad ØK, et al. Acta Ophthalmol. 2020 Dec;98(8):774-779. doi: 10.1111/aos.14177. Epub 2019 Jul 1. Acta Ophthalmol. 2020. PMID: 31264363 Free article.

9

Intravitreal therapy for retinal diseases in Norway 2011-2015.

Kristiansen IS, Haugli Bråten R, Jørstad ØK, Moe MC, Saether EM. Kristiansen IS, et al. Among authors: jorstad ok. Acta Ophthalmol. 2020 May;98(3):279-285. doi: 10.1111/aos.14262. Epub 2019 Oct 6. Acta Ophthalmol. 2020. PMID: 31587508 Free article.

10

Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study.

Jelin E, Wisløff T, Jørstad ØK, Heiberg T, Moe MC. Jelin E, et al. Among authors: jorstad ok. BMJ Open Ophthalmol. 2019 Oct 3;4(1):e000353. doi: 10.1136/bmjophth-2019-000353. eCollection 2019. BMJ Open Ophthalmol. 2019. PMID: 31673632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters